OTCM
XAGE
Market cap3mUSD
Oct 08, Last price
0.12USD
1D
0.00%
1Q
-46.54%
IPO
-98.77%
Name
Alpha Healthcare Acquisition Corp III
Chart & performance
P/E
—
P/S
1.89
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
2m
+3,701.44%
Net income
-7m
L-33.40%
CFO
-3m
L-24.14%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Alpha Healthcare Acquisition Corp. III currently lacks significant operational activities. This New York-based firm, established in 2021, is dedicated to executing a business combination—such as a merger, asset acquisition, stock exchange, or reorganization—with one or more entities. Its strategic focus is on identifying, acquiring, and managing a business within the United States' healthcare industry.
Key people
Rajiv Shukla
Executive Chairman of the Board, Chief Executive Officer · since 2025
Bryan Cassaday
Chief Financial Officer · since 2023
Patrick Sturgeon
Director · since 2023
David Anderson
Independent Director · since 2023
Scott Frisch
Independent Director · since 2023
Kathryn Gregory
Independent Director · since 2023
Gilles Spenlehauer
Independent Director · since 2023
Richard Upton
Independent Director · since 2023
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | |
| Income | |||||
Revenues | |||||
Cost of revenue | |||||
Unusual Expense (Income) | |||||
NOPBT | |||||
NOPBT Margin | |||||
Operating Taxes | |||||
Tax Rate | |||||
NOPAT | |||||
Net income | |||||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | |||||
| Cash flow | |||||
Cash from operating activities | |||||
CAPEX | |||||
Cash from investing activities | |||||
Cash from financing activities | |||||
FCF | |||||
| Balance | |||||
Cash | |||||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | |||||
Invested Capital | |||||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | |||||
Price | |||||
Market cap | |||||
EV | |||||
EBITDA | |||||
EV/EBITDA | |||||
Interest | |||||
Interest/NOPBT | |||||